[{"Assets_0_Q2_USD":162844000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-5356000.0,"NetIncomeLoss_1_Q2_USD":-241000.0,"NetIncomeLoss_2_Q2_USD":573000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":7486000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":7463000.0,"StockholdersEquity_0_Q2_USD":122922000.0,"EarningsPerShareBasic_1_Q2_USD":-0.03,"EarningsPerShareBasic_2_Q2_USD":0.08,"Ticker":"HSKA","CIK":"1038133","name":"HESKA CORP","OfficialName":"Heska Corporation Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1478587375.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20190807"}]